|
"pu ys"的相關文件
顯示項目 1-25 / 67 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2024-05-22 |
Predicting clinically significant prostate cancer using urine metabolomics via liquid chromatography mass spectrometry
|
Chen, CH;Huang, HP;Chang, KH;Lee, MS;Lee, CF;Lin, CY;Lin, YC;Huang, WJ;Liao, CH;Yu, CC;Chung, SD;Tsai, YC;Wu, CC;Ho, CH;Hsiao, PW;Pu, YS |
| 國家衛生研究院 |
2023-10-11 |
Prediction of clinically significant prostate cancer through urine metabolomic signatures: A large-scale validated study
|
Huang, HP;Chen, CH;Chang, KH;Lee, MS;Lee, CF;Chao, YH;Lu, SY;Wu, TF;Liang, ST;Lin, CY;Lin, YC;Liu, SP;Lu, YC;Shun, CT;Huang, WJ;Lin, TP;Ku, MH;Chung, HJ;Chang, YH;Liao, CH;Yu, CC;Chung, SD;Tsai, YC;Wu, CC;Chen, KC;Ho, CH;Hsiao, PW;Pu, YS |
| 臺大學術典藏 |
2021-02-03T08:23:12Z |
Transurethral resection of bladder tumors followed by radiotherapy with or without chemotherapy for bladder preservation in patients with invasive bladder transitional cell carcinoma: Preliminary NTUH experience.
|
Hsu FM; CHIA-HSIEN CHENG; Pu YS; Lin CC; Lai MK. |
| 臺大學術典藏 |
2021-02-03T08:09:54Z |
Nuclear factor-�eappa B overexpression is correlated with poor outcomes after multimodality bladder-preserving therapy in patients with muscle-invasive bladder Cancer.
|
Chiang Y; Wang CC; Tsai YC; Huang CY; Pu YS; Lin CC; CHIA-HSIEN CHENG |
| 臺大學術典藏 |
2018-09-10T05:02:40Z |
RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblasts
|
Tsuei, DJ;Hsu, HC;Lee, PH;Jeng, YM;Pu, YS;Chen, CN;Lee, YC;Chou, WC;Chang, CJ;Ni, YH;Chang, MH.; Tsuei, D.-J. and Hsu, H.-C. and Lee, P.-H. and Jeng, Y.-M. and Pu, Y.-S. and Chen, C.-N. and Lee, Y.-C. and Chou, W.-C. and Chang, C.-J. and Ni, Y.-H. and Chang, M.-H.; Liu, Chen-Hua; Tsuei, DJ; PO-HUANG LEE; Hsu, HC; Huang, Chung-Feng; MEI-HWEI CHANG; Lee, PH; Liu, Chun-Jen; CHIUNG-NIEN CHEN; YUNG-MING JENG; Dai, Chia-Yen; Jeng, YM; Yen-Hsuan Ni; Huang, Jee-Fu; Pu, YS; Chen, CN; Lin, Jou-Wei; YEONG-SHIAU PU; Lee, YC; Liang, Cheng-Chao; Chou, WC; Yang, Sheng-Shun; Lin, Chih-Lin; Chang, CJ; Su, Tung-Hung; Ni, YH; Yang, Hung-Chih; Chang, MH.; Chen, Pei-Jer; Chen, Ding-Shinn; Chuang, Wan-Long; Kao, Jia-Horng; Yu, Ming-Lung; 陳定信; 劉振驊; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 林昭維 |
| 臺北醫學大學 |
2014 |
Comparison of Genome-wide DNA Methylation in Urothelial Carcinomas of Patients with and without Arsenic Exposure
|
Yang, TY;Hsu, LI;Chiu, AW;Pu, YS;Wang, SH;Liao, YT;Wu, MM;Wang, YH;Chang, CH;Lee, TC;Chen, CJ |
| 臺北醫學大學 |
2014 |
XRCC1 Arg194Trp and Arg399Gln polymorphisms and arsenic methylation capacity are associated with urothelial carcinoma
|
Chiang, CI;Huang, YL;Chen, WJ;Shiue, HS;Huang, CY;Pu, YS;Lin, YC;Hsueh, YM |
| 國家衛生研究院 |
2013-01-10 |
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma
|
Chung, CJ;Pu, YS;Shiue, HS;Lee, HL;Lin, P;Yang, HY;Su, CT;Hsueh, YM |
| 臺北醫學大學 |
2013 |
Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma
|
Wu, CC;Huang, YK;Chung, CJ;Huang, CY;Pu, YS;Shiue, HS;Lai, LA;Lin, YC;Su, CT;Hsueh, YM |
| 臺北醫學大學 |
2013 |
Environmental tobacco smoke and arsenic methylation capacity are associated with urothelial carcinoma
|
Wu, CC;Chen, MC;Huang, YK;Huang, CY;Lai, LA;Chung, CJ;Shiue, HS;Pu, YS;Lin, YC;Han, BC;Wang, YH;Hsueh, YM |
| 臺北醫學大學 |
2013 |
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism-related enzymes gene polymorphisms, NNK metabolites levels and urothelial carcinoma
|
Chung, CJ;Pu, YS;Shiue, HS;Lee, HL;Lin, P;Yang, YH;Su, CT;Hsueh, YM |
| 臺北醫學大學 |
2013 |
The effect of cigarette smoke and arsenic exposure on urothelial carcinoma risk is modified by glutathione S-transferase M1 gene null genotype
|
Chung, CJ;Huang, CY;Pu, YS;Shiue, HS;Su, CT;Hsueh, YM |
| 國家衛生研究院 |
2012-12 |
A Cullin3-KLHL20 ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression
|
Lee, YR;Yuan, WC;Huang, SF;Lin, YM;Chen, TY;Chung, HC;Tsai, CH;Chen, HY;Chiang, CT;Lai, CK;Lu, LT;Chen, CH;Gu, DL;Pu, YS;Jou, YS;Lu, K;Hsiao, PW;Shih, HM;Chen, RH |
| 國家衛生研究院 |
2012-11 |
Joint effect of arsenic methylation profile and NNK metabolites on urothelial carcinoma
|
Wu, CC;Su, CT;Lee, HL;Chung, CJ;Huang, CY;Pu, YS;Lin, P;Hsueh, YM |
| 國家衛生研究院 |
2011-08 |
A Cullin3-KLHL20 ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression
|
Yuan, WC;Lee, YR;Huang, SF;Lin, YM;Chen, TY;Chung, HC;Tsai, CH;Chen, HY;Chiang, CT;Lai, CK;Lu, LT;Chen, CH;Gu, DL;Pu, YS;Jou, YS;Lu, KP;Hsiao, PW;Shih, HM;Chen, RH |
| 中國醫藥大學 |
2011-08 |
Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy
|
(Huang SP)*; 鮑柏穎(Bo-Ying Bao); (Wu MT); (Choueiri TK); (Goggins WB); (Huang CY); (Pu YS); (Yu CC); (Huang CH) |
| 國家衛生研究院 |
2011-04 |
Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk
|
Chung, CJ;Lee, HL;Yang, HY;Lin, P;Pu, YS;Shiue, HS;Su, CT;Hsueh, YM |
| 中國醫藥大學 |
2011-02 |
Polymorphisms inside MicroRNAs and MicroRNA Target Sites Predict Clinical Outcomes in Prostate Cancer Patients Receiving Androgen-Deprivation Therapy.
|
鮑柏穎(Bo-Ying Bao); (Pao JB); (Huang CN); (Pu YS); 張大元(Ta-Yuan Chang); 藍于琁(Lan Yu Hsuan); 陸德齡(Lu Te-Ling); 李鳳琴(Hong-Zin Lee); 莊聲宏(Shin-Hun Juang); 陳璐敏(Lu-Min Chen); (Hsieh CJ); (Huang SP)* |
| 高雄醫學大學 |
2011 |
Reversed association between levels of prostate specific antigen and levels of blood cadmium and urinary cadmium.
|
楊俊毓; Wu, CC;Pu, YS;Wu, HC;Yang, CY;Chen, YC |
| 中國醫藥大學 |
2011 |
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy
|
鮑柏穎(Bo-Ying Bao); (Pao JB); (Huang CN); (Pu YS); 張大元(Ta-Yuan Chang); 藍于琁(Lan Yu Hsuan); 陸德齡(Lu Te-Ling); 李鳳琴(Hong-Zin Lee); 陳璐敏(Lu-Min Chen); (Ting WC); (Hsieh CJ); (Huang SP)* |
| 中國醫藥大學 |
2011 |
Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy
|
(Huang CN); (Huang SP); (Pao JB); 張大元(Ta-Yuan Chang); 藍于琁(Lan Yu Hsuan); 陸德齡(Lu Te-Ling); 李鳳琴(Hong-Zin Lee); 莊聲宏(Shin-Hun Juang); 吳玢玢(Wu Ping-Ping); (Pu YS); (Hsieh CJ); 鮑柏穎(Bo-Ying Bao)* |
| 中國醫藥大學 |
2011 |
Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy
|
(Huang SP)*; 鮑柏穎(Bo-Ying Bao); (Wu MT); (Choueiri TK); (Goggins WB); (Liu CC); (Huang CY); (Pu YS); (Yu CC); (Wu TT); (Huang CN); (Huang CH); (Wu WJ) |
| 中山醫學大學 |
2010 |
Ling-Zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells.
|
Huang, CY; Chen, JY; Wu, JE; Pu, YS; Liu, GY; Pan, MH; Huang, YT; Huang, AM; Hwang, CC; Chung, SJ; Hour, TC |
| 高雄醫學大學 |
2010 |
2';5'-dimethoxychalcone及其衍生物對微管作用之研究
|
涂皇堯;黃阿梅;侯自銓;楊世群;蒲永孝;林忠男 ; Tu HY;Huang AM;Hour TC;Yang SC;Pu YS;Lin CN |
| 高雄醫學大學 |
2010 |
靈芝萃取物協同增強抗癌藥物毒殺具抗藥性之泌尿上皮癌細胞
|
黃昭淵;陳逸夫;吳嘉恩;蒲永孝;劉光耀;潘敏雄;黃胤塘;黃阿梅;黃啟清;侯自銓 ; Huang CY;Chen Jeff YF;Wu JE;Pu YS;Liu GY;Pan MH;Huang YT;Huang AM;Hwang CC;Chung SJ;Hour TC |
顯示項目 1-25 / 67 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
